Condition
Abnormal Uterine Bleeding, Unspecified
Total Trials
5
Recruiting
0
Active
2
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Active Not Recruiting2
Completed1
Unknown1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07465822Active Not RecruitingPrimary
The Learning Curve of a Gynecology and Obstetrics Resident Performing Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) Hysterectomy in a University Hospital
NCT06888414Active Not RecruitingPrimary
Evaluation of the Uterine Cavity in Perimenopausal Women.
NCT02059954Not ApplicableCompleted
Vaginal vs. Laparoscopic Hysterectomy
NCT01963403Phase 4TerminatedPrimary
Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive
NCT01929148Not ApplicableUnknownPrimary
Prophylactic Bilateral Salpingectomy and Laparoscopic Myomectomy
Showing all 5 trials